.We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.” We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.” We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.”
PHARMACOLOGICAL PREVENTION OF POSTANESTHETIC SHIVERING / Bilotta, F; Rosa, Giovanni. - In: ANESTHESIA AND ANALGESIA. - ISSN 0003-2999. - STAMPA. - 95(4):(2002), pp. 1125-1126.
PHARMACOLOGICAL PREVENTION OF POSTANESTHETIC SHIVERING
BILOTTA F;ROSA, Giovanni
2002
Abstract
.We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.” We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.” We question why in their study investigating drugs for preventing postanesthetic shivering Piper et al compared placebo with dolas- etron and clonidine (1). We also wonder why they state that “a dose-response study would be scientifically important and econom- ically justified only if its side-effect profile were significantly supe- rior to that of established drugs.”I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
